×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
Title
Creator
Date Issued
Subject Area
Keyword
Document Type
Source Publication
Date Accessioned
Indexed By
Publisher
Funding Project
MOST Discipline Catalogue
Study Hall
Image search
Paste the image URL
Home
Collections
Authors
DocType
K-Map
News
Search in the results
Collection
Faculty of... [8]
Institute ... [4]
Authors
XIANG YUTA... [7]
CHEN XIUPI... [2]
WANG YITAO [1]
LEE MING Y... [1]
ZHENG WENH... [1]
Document Type
Journal a... [18]
论文 [4]
Date Issued
2021 [2]
2020 [1]
2019 [1]
2018 [4]
2017 [2]
2016 [2]
More...
Language
英语 [12]
英語 [10]
Source Publication
Internatio... [7]
Journal of... [7]
Pharmacolo... [5]
JOURNAL OF... [2]
PHARMACOLO... [1]
Funding Project
Indexed By
SCI [7]
Funding Organization
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-10 of 22
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
Title Ascending
Title Descending
Submit date Ascending
Submit date Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Author Ascending
Author Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
Combination therapy with PD-1/PD-L1 blockade in non-small cell lung cancer: strategies and mechanisms
Journal article
Pharmacology and Therapeutics, 2021,Volume: 219
Authors:
Huang,Mu Yang
;
Jiang,Xiao Ming
;
Wang,Bing Lin
;
Sun,Yang
;
Lu,Jin Jian
Favorite
|
View/Download:0/0
|
TC[WOS]:
0
TC[Scopus]:
0
|
Submit date:2021/03/02
challenge
combination therapy
immunotherapy
mechanism
NSCLC
PD-1/PD-L1
Combination therapy with PD-1/PD-L1 blockade in non-small cell lung cancer: strategies and mechanisms
Journal article
Pharmacology and Therapeutics, 2021,Volume: 219
Authors:
Huang,Mu Yang
;
Jiang,Xiao Ming
;
Wang,Bing Lin
;
Sun,Yang
;
Lu,Jin Jian
Favorite
|
View/Download:0/0
|
TC[WOS]:
0
TC[Scopus]:
0
|
Submit date:2021/03/02
challenge
combination therapy
immunotherapy
mechanism
NSCLC
PD-1/PD-L1
Induction of programmed necrosis: A novel anti-cancer strategy for natural compounds
Journal article
Pharmacology and Therapeutics, 2020,Volume: 214
Authors:
Yu,Jie
;
Zhong,Bingling
;
Xiao,Qingwen
;
Du,Lida
;
Hou,Ying
;
Sun,Hong Shuo
;
Lu,Jin Jian
;
Chen,Xiuping
Favorite
|
View/Download:0/0
|
TC[WOS]:
4
TC[Scopus]:
4
|
Submit date:2021/03/01
Cancer
Natural compounds
Programmed necrosis
The sphingosine kinase-1/sphingosine-1-phosphate axis in cancer: Potential target for anticancer therapy
Journal article
Pharmacology and Therapeutics, 2019,Volume: 195,Page: 85-99
Authors:
Zheng,Xiangjin
;
Li,Wan
;
Ren,Liwen
;
Liu,Jinyi
;
Pang,Xiaocong
;
Chen,Xiuping
;
Kang,De
;
Wang,Jinhua
;
Du,Guanhua
Favorite
|
View/Download:1/0
|
TC[WOS]:
20
TC[Scopus]:
21
|
Submit date:2021/03/01
Cancer
Inhibitor
Mechanism
Sphingosine kinase 1
Signalling pathways regulating galactosaminoglycan synthesis and structure in vascular smooth muscle: Implications for lipoprotein binding and atherosclerosis
Journal article
PHARMACOLOGY & THERAPEUTICS, 2018,Volume: 187,Page: 88-97
Authors:
Afroz, Rizwana
;
Cao, Yingnan
;
Rostam, Muhamad Ashraf
;
Ta, Hang
;
Xu, Suowen
;
Zheng, Wenhua
;
Osman, Narin
;
Kamato, Danielle
;
Little, Peter J.
Favorite
|
View/Download:33/0
|
TC[WOS]:
13
TC[Scopus]:
14
|
Submit date:2018/10/30
Atherosclerosis
Proteoglycans
Galactosaminoglycans
Signalling Pathways
Flavopiridol inhibits TGF-b-stimulated biglycan synthesis by blocking linker region phosphorylation and nuclear translocation of Smad2
Journal article
Journal of Pharmacology and Experimental Therapeutics, 2018,Volume: 365,Issue: 1,Page: 156-164
Authors:
Rostam M.A.
;
Shajimoon A.
;
Kamato D.
;
Mitra P.
;
Piva T.J.
;
Getachew R.
;
Cao Y.
;
Zheng W.
;
Osman N.
;
Little P.J.
Favorite
|
View/Download:7/0
|
TC[WOS]:
16
TC[Scopus]:
15
|
Submit date:2018/12/21
Flavopiridol Inhibits TGF-beta-Stimulated Biglycan Synthesis by Blocking Linker Region Phosphorylation and Nuclear Translocation of Smad2
Journal article
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2018,Volume: 365,Issue: 1,Page: 156-164
Authors:
Rostam, Muhamad A.
;
Shajimoon, Aravindra
;
Kamato, Danielle
;
Mitra, Partha
;
Piva, Terrence J.
;
Getachew, Robel
;
Cao, Yingnan
;
Zheng, Wenhua
;
Osman, Narin
;
Little, Peter J.
Favorite
|
View/Download:22/0
|
TC[WOS]:
16
TC[Scopus]:
15
|
Submit date:2018/10/30
Berberine upregulates P-glycoprotein in human caco-2 cells and in an experimental model of colitis in the rat via activation of Nrf2-dependent mechanismss
Journal article
Journal of Pharmacology and Experimental Therapeutics, 2018,Volume: 366,Issue: 2,Page: 332
Authors:
Jing W.
;
Safarpour Y.
;
Zhang T.
;
Guo P.
;
Chen G.
;
Wu X.
;
Fu Q.
;
Wang Y.
Favorite
|
View/Download:25/0
|
TC[WOS]:
13
TC[Scopus]:
17
|
Submit date:2018/10/31
Novel phosphodiesterase 4 inhibitor FCPR03 alleviates lipopolysaccharide-induced neuroinflammation by regulation of the cAMP/PKA/CREB signaling pathway and NF-κB inhibition
Journal article
Journal of Pharmacology and Experimental Therapeutics, 2017,Volume: 362,Issue: 1,Page: 67-77
Authors:
Zou Z.-Q.
;
Chen J.-J.
;
Feng H.-F.
;
Cheng Y.-F.
;
Wang H.-T.
;
Zhou Z.-Z.
;
Guo H.-B.
;
Zheng W.
;
Xu J.-P.
Favorite
|
View/Download:8/0
|
TC[WOS]:
16
TC[Scopus]:
19
|
Submit date:2018/12/21
Novel Phosphodiesterase 4 Inhibitor FCPR03 Alleviates Lipopolysaccharide-Induced Neuroinflammation by Regulation of the cAMP/PKA/CREB Signaling Pathway and NF-kappa B Inhibition
Journal article
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2017,Volume: 362,Issue: 1,Page: 67-77
Authors:
Zou, Zheng-Qiang
;
Chen, Jia-Jia
;
Feng, Hong-Fang
;
Cheng, Yu-Fang
;
Wang, Hai-Tao
;
Zhou, Zhong-Zhen
;
Guo, Hai-Biao
;
Zheng, Wenhua
;
Xu, Jiang-Ping
Favorite
|
View/Download:29/0
|
TC[WOS]:
17
TC[Scopus]:
19
|
Submit date:2018/10/30